User contributions
Jump to navigation
Jump to search
- 01:36, 2 May 2024 diff hist -2 Main Page current
- 01:34, 2 May 2024 diff hist -36 Main Page
- 12:55, 20 April 2024 diff hist +3 m Head and neck cancer Text replacement - "Reported efficacy based" to "Reported efficacy is based"
- 12:54, 20 April 2024 diff hist +3 m Peripheral T-cell lymphoma Text replacement - "Reported efficacy based" to "Reported efficacy is based"
- 17:14, 16 April 2024 diff hist -1 m ASCO guidelines Text replacement - "old-prod.asco.org" to "society.asco.org"
- 20:16, 15 April 2024 diff hist 0 Classical Hodgkin lymphoma, pediatric
- 20:07, 15 April 2024 diff hist -1 Hepatoblastoma current
- 20:04, 15 April 2024 diff hist -29 Rhabdomyosarcoma, pediatric →Low Risk current
- 20:03, 15 April 2024 diff hist +17 Rhabdomyosarcoma, pediatric →Intermediate Risk
- 20:01, 15 April 2024 diff hist -16 Gestational trophoblastic neoplasia current
- 19:59, 15 April 2024 diff hist 0 Rhabdomyosarcoma, pediatric - historical current
- 19:57, 15 April 2024 diff hist +17 Rhabdomyosarcoma, pediatric →High Risk
- 19:57, 15 April 2024 diff hist +18 Neuroblastoma - historical →High Risk current
- 12:19, 3 April 2024 diff hist 0 m Breast cancer, HER2-positive Text replacement - "PRO Analysis:" to "PRO analysis:"
- 12:17, 3 April 2024 diff hist 0 m Light-chain (AL) amyloidosis Text replacement - "HRQoL Analysis:" to "HRQoL analysis:"
- 23:43, 27 March 2024 diff hist +994 Editorial Board current
- 23:31, 27 March 2024 diff hist -285 Editorial board transclusions →Plasma cell dyscrasia current
- 00:42, 27 March 2024 diff hist 0 m Testicular cancer Text replacement - "cycles, given" to "cycles; given"
- 00:42, 27 March 2024 diff hist 0 m Multiple myeloma - historical Text replacement - "cycles, given" to "cycles; given"
- 00:42, 27 March 2024 diff hist 0 m Multiple myeloma, induction Text replacement - "cycles, given" to "cycles; given"